SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 24, 2003
RESPIRONICS, INC.
(Exact name of Registrant as specified in its charter)
| Delaware | 000-16723 | 25-1304989 | ||
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification Number) |
| 1010 Murry Ridge Lane | ||
| Murrysville, Pennsylvania | 15668-8525 | |
| (Address of Principal Executive Offices) | (Zip Code) |
724-387-5200
(Registrant’s telephone number, including area code)
| 2 | ||
| 3 | ||
| 4 | ||
| EX-99 PRESS RELEASE |
Table of Contents
Item 9. REGULATION FD DISCLOSURE.
The following information is furnished pursuant to Item 12, “Disclosure of Results of Operations and Financial Condition.”
On July 24, 2003, Respironics Inc. issued a press release announcing its financial results for the three months and fiscal year ended June 30, 2003. A copy of the press release is attached hereto as Exhibit 99.
| Exhibits |
||
| 99 | Press release, dated July 24, 2003, issued by Respironics, Inc. | |
2
Table of Contents
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| RESPIRONICS, INC. | ||
| By: |
/s/ Daniel J. Bevevino | |
| Daniel J. Bevevino Vice President, and Chief Financial and Principal Accounting Officer | ||
Dated: July 24, 2003
3
Table of Contents
| Exhibit No. |
Description | |
| 99 | Press release, dated July 24, 2003, issued by Respironics, Inc. | |
4